azelastine has been researched along with montelukast in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Li, S; Tao, J; Wu, Y; Xu, Y; Zhou, H | 1 |
Grönke, L; Janicki, S; Jörres, RA; Magnussen, H; Maus, J; Richter, K | 1 |
Alyasin, S; Babaeian, M; Esmaeilzadeh, H; Far, NM; Hadipour, M; Nabavizadeh, SH | 1 |
2 trial(s) available for azelastine and montelukast
Article | Year |
---|---|
Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma.
Topics: Acetates; Adult; Anti-Allergic Agents; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phthalazines; Quinolines; Respiratory Function Tests; Sulfides | 2008 |
A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial.
Topics: Acetates; Administration, Intranasal; Adolescent; Adrenal Cortex Hormones; Adult; Asthma; Budesonide; Cyclopropanes; Double-Blind Method; Histamine Antagonists; Histamine H1 Antagonists; Humans; Nasal Sprays; Phthalazines; Quality of Life; Quinolines; Rhinitis, Allergic; Sulfides; Treatment Outcome; Young Adult | 2022 |
3 other study(ies) available for azelastine and montelukast
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Expression of urocortin in rat lung and its effect on pulmonary vascular permeability.
Topics: Acetates; Administration, Inhalation; Aerosols; Animals; Blotting, Western; Bronchi; Capillary Permeability; Corticotropin-Releasing Hormone; Cromolyn Sodium; Cyclopropanes; Epithelium; Histamine H1 Antagonists; Immunohistochemistry; Leukotriene Antagonists; Lung; Male; Mast Cells; Ovalbumin; Peptide Fragments; Phthalazines; Pulmonary Alveoli; Quinolines; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfides; Urocortins | 2006 |